logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jasper J. Brugts

Erasmus MC
H指数:39
被引数:7,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences between men and women in guideline-directed medical therapy implementation, tolerability, and outcomes in heart failure with reduced ejection fraction

心衰射血分数降低患者中，男性和女性在指南指导下的药物治疗实施、耐受性和结局方面的差异

European Heart Journal - Quality of Care and Clinical Outcomes
IF0
2026-07-250
OAAI
Mariëlle I Wilde; Joris J N Krabbe; Lex J Bouhuijzen; Gerardus P J van Hout; Michelle M de Leau; Ka wai Wu; Eugène A van Beek; Tim Hesselink; Lennaert Kleijn; Maurice J M Kurvers; René A Tio; Crystel M Gijsberts; Chahinda Ghossein-Doha; Peter van der Meer; Rudolf A de Boer; Hans-Peter Brunner-La Rocca; Stefan Koudstaal; Jasper J Brugts; null
The Impact of a Gamified Engagement Toolkit on Heart Failure Registry Participation: Results of the Engage-HF Study

游戏化参与工具包对心力衰竭登记参与的影响：Engage-HF研究的结果

European Journal of Cardiovascular Nursing
IF3.9
2026-04-070
OA
Abdul Shakoor, MD; Niels Scholte, MD; Rik van de Kamp, MSc; Lineke Derks, MSc; C Jan Willem Borleffs, MD, PhD; Gert K van Houwelingen, MD; Julio E C van de Swaluw, MD, PhD; Roland van Kimmenade, MD, PhD; Amber Otten, MD, PhD; Ron Pisters, MD, PhD; Clara E E van Ofwegen-Hanekamp, MD, PhD; Stefan Koudstaal, MD, PhD; Folkert W Asselbergs, MD, PhD; Dennis van Veghel, MSc, PhD; Sandra S van Wijk, MD, PhD; M Louis Handoko, MD, PhD; Robert M A van der Boon, MD, PhD; Jasper J Brugts, MD, PhD; Jeroen Schaap, MD, PhD
Proteomic Biomarkers Are Linked to QTc Interval in Patients With Chronic Heart Failure

蛋白质组学生物标志物与慢性心力衰竭患者的QTc间期相关联

PROTEOMICS CLINICAL APPLICATIONS
IF0
2025-09-010
OAAI
Barry-Loncq de Jong, Mylene; Petersen, Teun B.; Abou Kamar, Sabrina; Suthahar, Navin; van Boven, Nick; Akkerhuis, K. Martijn; van der Spek, Peter J.; Katsikis, Peter D.; de Boer, Rudolf A.; Umans, Victor A. W. M.; Boersma, Eric; Asselbergs, Folkert W.; Brugts, Jasper J.; Yap, Sing-Chien; Kardys, Isabella
Angiotensin–Neprilysin Inhibition and Left Ventricular Assist Device Therapy –Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

血管紧张素-中性肽链内切酶抑制与左心室辅助装置疗法——多中心、随机、开放标签、平行组研究评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中应用的主要结果（ENVAD-HF）

jacc heart failure
IF0
2025-08-310
OAAI
Maja Cikes; Jasper J. Brugts; Brian Claggett; Ulrich P. Jorde; Davor Milicic; Ivo Planinc; Frank Ruschitzka; Nir Uriel; Ian Kulac; Nina Jakus; Filip Loncaric; Filip Puskaric; Dubravka Sipus; Hrvoje Gasparovic; Pawel Rubis; Linda W. van Laake; Igor Rudez; Marketa Hegarova; Gloria Sestan; Sylwia Wisniowska-Smialek; Karol Wierzbicki; Mandeep R. Mehra; Scott D. Solomon
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

心力衰竭伴射血分数降低的指南推荐药物治疗真实世界实施：对预后和左心室射血分数的影响。TITRATE-HF研究主要结果

European Journal of Heart Failure
IF10.8
2025-08-140
PREAI
Jishnu Malgie; Mariëlle I. Wilde; Stefan Koudstaal; Robert Denham; Carlos A. da Fonseca; Henk P. Swart; Clara E.E. van Ofwegen; Ayten Yilmaz; Ron Pisters; Gerard C.M. Linssen; Nikola Faber; Loek van Heerebeek; Julio E.C. van de Swaluw; Rudolf A. de Boer; Hans-Peter Brunner-La Rocca; Jasper J. Brugts
Rationale, design and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

研究背景、设计与基线特征：一项多中心、随机、开放标签、平行分组研究，旨在评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中的使用（ENVAD-HF研究）。

Journal of Cardiac Failure
IF8.2
2025-08-140
PREAI
Maja Cikes; Ivo Planinc; Jasper J Brugts; Brian Claggett; Ulrich P. Jorde; Davor Milicic; Frank Ruschitzka; Nir Uriel; Nina Jakus; Filip Loncaric; Filip Puskaric; Pawel Rubis; Linda W. van Laake; Igor Rudez; Marketa Hegarova; Mandeep Mehra; Scott D. Solomon
Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction

射血分数降低的心力衰竭患者中与心房颤动相关的蛋白质组学生物标志物和生物学通路

heart rhythm
IF2.9
2025-06-160
OAAI
Teun B. Petersen; Mylène Barry-Loncq de Jong; Jie Fen Chin; Navin Suthahar; Peter J. van der Spek; Peter D. Katsikis; K. Martijn Akkerhuis; Victor A. Umans; Rudolf A. de Boer; Bas M. van Dalen; Jasper J. Brugts; Folkert W. Asselbergs; Eric Boersma; Dimitris Rizopoulos; Sing-Chien Yap; Isabella Kardys
The Association Between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures Measured by Invasive Hemodynamic Monitoring

连续测量的循环生物标志物模式与通过侵入性血流动力学监测测量的肺动脉压力之间的关联

Journal of Cardiac Failure
IF8.2
2025-05-230
OAAI
MYLÈNE BARRY-LONCQ DE JONG; YOUSSRA ALLACH; SABRINA ABOU KAMAR; PASCAL R.D. CLEPHAS; HANS-PETER BRUNNER-LA ROCCA; M. LOUIS HANDOKO; VOKKO P. VAN HALM; WOUTER E.M. KOK; FOLKERT W. ASSELBERGS; ROLAND R.J. VAN KIMMENADE; SASKIA L.M.A. BEERES; MICHIEL RIENSTRA; MARIUSZ K. SZYMANSKI; RUDOLF A. DE BOER; ISABELLA KARDYS; JASPER J. BRUGTS
Heart failure: assessment of the global economic burden

Darvish, M.; Shakoor, A.; Feyz, L.; Schaap, J.; van Mieghem, N.M.; de Boer, R.A.; Brugts, J.J.; van der Boon, R.M.A. 心力衰竭：全球经济负担评估。Eur. Heart J. 2025, 46, 3069–3078. [Google Scholar] [CrossRef]

EUROPEAN HEART JOURNAL
IF35.6
2025-05-0112
OA
Darvish, Mohammad; Shakoor, Abdul; Feyz, Lida; Schaap, Jeroen; van Mieghem, Nicolas M.; de Boer, Rudolf A.; Brugts, Jasper J.; van der Boon, Robert M. A.
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

远程肺动脉压力引导的心力衰竭患者管理：欧洲心脏病学会（ESC）心力衰竭协会（HFA）的临床共识声明

EUROPEAN JOURNAL OF HEART FAILURE
IF10.8
2025-04-270
OAAI
Antoni Bayes-Genis; Matteo Pagnesi; Pau Codina; William T. Abraham; Offer Amir; Rudolf A. de Boer; Jasper J. Brugts; Ovidiu Chioncel; Finn Gustafsson; JoAnn Lindenfeld; Wilfried Mullens; Mark C. Petrie; Giuseppe Rosano; Marco Metra
Hypertension and cardiometabolic disorders appear 5-10 years earlier in women with pre-eclampsia

子痫前期女性的高血压和心血管代谢紊乱出现时间比普通女性早5-10年。

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
IF7.5
2025-04-230
PRE
Janssen, Emma B. N. J.; Ghossein-Doha, Chahinda; Hooijschuur, Mieke C. E.; Mulder, Eva G.; Schiffer, Veronique M. M. M.; Alers, Robert-Jan; Jorissen, Laura M.; Jansen, Gwyneth E.; Kroon, Abraham A.; Brugts, Jasper J.; van 't Hof, Arnoud W. J.; Spaanderman, Marc E. A.

研究方向

暂未获取到该数据
O
Olivier C. Manintveld
H 指数:36论文数:310被引数:9,788
K
Kadir Çalişkan
H 指数:44论文数:385被引数:6,784
E
Eric Boersma
H 指数:129论文数:1,020被引数:6.5万
A
Alina A. Constantinescu
H 指数:28论文数:135被引数:2,706
I
Isabella Kardys
H 指数:42论文数:424被引数:7,118
R
Rudolf A. de Boer
H 指数:129论文数:1,013被引数:8.2万
J
Jesse F. Veenis
H 指数:16论文数:59被引数:660
F
Folkert W. Asselbergs
H 指数:103论文数:1,079被引数:5.6万
K
K. Martijn Akkerhuis
H 指数:42论文数:221被引数:6,942
H
Hans‐Peter Brunner‐La Rocca
H 指数:75论文数:512被引数:3.0万